The Coronary Artery Bypass Graft (CABG) Market is expected to witness a rapid surge in demand during the forecast period, i.e., 2021 – 2028. Coronary Artery Bypass Graft (CABG) is a type of surgery performed in patients suffering from coronary heart disease (CHD). CHD is a condition in the heart where fat, cholesterol and other substances combine to form a layer called plaque inside arteries of the human heart which are then treated using various methods of surgery. CHD is prone to the majority of people who are suffering from diabetes. Consumption of excessive fat-containing food products, unhealthy lifestyle, and obesity are the major causes of this disease to prevail across the globe. Various methods of surgery are used to treat CHD and create a new path for the blood to flow to the heart. The number of CHD patients is only increasing with time as a result of enhancing the rise of the market.
Social media and various wellness programs or campaigns have been started by the government and NGOs to create awareness among people and are a major driver of market growth. Also, the rise of heart-related chronic diseases and unhealthy lifestyles among youth and people are fuelling the growth of the Coronary Artery Bypass Graft market. The few restraints of the Coronary Artery Bypass Graft market are the high implementation cost of equipment required for surgery, the high cost of surgery which is still unaffordable to many people, and the lack of skills in doctors and specialists is a major setback to the coronary artery bypass graft market.
Scope and Segmentation of Market
The report is primary research on the growth of the coronary artery bypass graft market because the market seems to grow gradually with time as the number of patients developing CHD is increasing gradually with the advancement and modernization of technology. The analysis of the coronary artery bypass graft market has been done through extensive research on market dynamics, its restraints or challenges, and opportunities. The market is expected to grow in the near future; a detailed study on the coronary artery bypass graft market has been presented in this report. It includes accurate data representation of market growth, profit, and the key players of this market. The coronary artery bypass graft market is segmented on basis of by technology, by surgical methods, by products & services, by techniques, by types, by end-users, and by regions. By technology, the coronary artery bypass graft market can be segmented by off-pump CABG and on-pump CABG. By surgical methods, the coronary artery bypass graft market can be segmented by single CABG surgery, double CABG surgery, triple CABG surgery, and quadruple CABG surgery. By products & services, the market can be divided into grafts, services, retractors, and others. By technique, the market can be bifurcated into conventional vessel harvesting and Endoscopic Vessel Harvesting. By type, market can be divided into Internal Thoracic Artery Grafts, Saphenous Vein Grafts, and other Grafts which also include Gastroepiploic Artery and Radial Artery. By End-users market can be classified into hospitals, cardiology clinics, research institutes & laboratories, and others, By region, the coronary artery bypass graft market is spread across North America, Europe, Asia Pacific, and the Rest of the World (RoW).
Key Players of Market
The prominent players of the market who have the largest share are Medtronic Plc, Getinge AB, Terumo Medical Corporation, Genesee Biomedical Inc, Karl Storz SE & Co KG, Hancock Jaffe Laboratories, Inc., Terumo Cardiovascular Systems Corporation, VasoPrep Surgical, Dextera Surgical Inc., Neograft Inc., NOVADAQ Technologies Inc., MAQUET Holding B.V. & Co. KG., Sorin Group, Edwards LifesciencesCorporation, Medtronic, TERUMO CORPORATION, Guidant Group; Vitalitec International, Inc., Novadaq Technologies Inc. and among others.
By Surgical Methods
By Products & Services